NCT06685835 A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06178783 A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT06013241 A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Status COMPLETED Phase PHASE2
NCT05965570 A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants Status COMPLETED Phase PHASE1
NCT05826574 A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants Status COMPLETED Phase PHASE1
NCT05673603 A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment Status COMPLETED Phase PHASE1
NCT05517525 A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT05355935 A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants Status COMPLETED Phase PHASE1
NCT05344508 An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis Status APPROVED_FOR_MARKETING Phase N/A
NCT05090904 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT04817332 STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19 Status COMPLETED Phase PHASE3